MCH (salmon) [5019]



MCH (salmon)


SMILES CSCC[C@H](NC(=O)[C@H](CS)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)O)C(C)C)C(C)C)C(C)C
InChIKey RNKJDHAVPKDCSA-KHBOZDSRSA-N
Sequence DTMRCMVGRVYRPCWEV
HELM PEPTIDE1{D.T.M.R.C.M.V.G.R.V.Y.R.P.C.W.E.V}$$$$

Chemical Properties

Hydrogen bond acceptors 29
Hydrogen bond donors 30
Rotatable bonds 65
Log P -6.820
Molecular weight (Da) 2100.0
Stereochemistry info partial

Database connections

Model (AF2) MCH2


Bioactivities

Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database
Receptor Activity Source
Protein Gene Species Family Class Type Min Avg Max Database

MCH (salmon)


Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Model (AF2) MCH2


Compound is not listed as a drug.